Stratview Research publishes a new report titled Oncology Drugs Market which is segmented By Drug Class (Cytotoxic drugs, Targeted drugs, Hormonal drugs, Others), By Therapy (Chemotherapy, Targeted therapy, Immunotherapy), By Indication (Blood Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Others) and Region.
The Global Oncology Drugs Market is projected to grow from USD 182.56 billion in 2020 to USD 340.27 billion by 2026 at a CAGR of over 10.9% during the forecast period. Increasing incidence of different types of cancers, strong technological advancements, rising concern over high death rates due to cancer, and a surge in the need for better R&D activities in cancer treatment are some of the key drivers augmenting the product demand.
Moreover, the introduction of new therapies and drugs for cancer and government support to enhance the healthcare facilities are further expected to promulgate the demand for oncology drugs. However, strict government regulations and the high cost of cancer treatments are likely to hinder the industry's growth.
Key players active in the market –
The following are some of the key players in the Oncology Drugs Market:
- Hoffmann-La Roche AG (Switzerland),
- Novartis AG (Switzerland),
- Bristol-Myers Squibb Company (The U.S),
- Merck & Co., Inc. (The U.S),
- Johnson & Johnson (The U.S),
- Pfizer Inc. (The U.S),
- AstraZeneca (UK),
- AbbVie Inc. (The U.S),
- Astellas Pharma Inc. (Japan), and
- CELGENE CORPORATION (The U.S).
Click here to get a free sample : https://www.stratviewresearch.com/Request-Sample/1724/oncology-drugs-market.html#form
Customization of the report –
At Stratview Research, the market researchers make a note of opportunities, drawbacks/bottlenecks, estimations, and information related to the market using experienced skills and verified methodologies. Our research reports offer an exceptional experience of innovative solutions and outcomes to the users. If required, user can also opt for customization of the report.
Connect with our team at –
E-mail: [email protected]